Taho Pharmaceuticals Ltd. (TPEX:6467)

Taho Pharmaceuticals Revenue

Taho Pharmaceuticals had revenue of 7.78M TWD in the half year ending June 30, 2025, with 296.89% growth. This brings the company's revenue in the last twelve months to 7.78M.

• Revenue (ttm): 7.78M
• Revenue Growth: n/a
• P/S Ratio: 786.15
• Revenue / Employee: 288.11K
• Employees: 27
• Market Cap: 6.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	1.07M	-5.29M	-83.23%
Dec 31, 2022	6.36M	-6.04M	-48.73%
Dec 31, 2017	12.40M	-23.61M	-65.57%
Dec 31, 2016	36.01M	939.00K	2.68%